Pulse pressure is the difference between systole and diastole blood pressure. It is measured in millimeters of mercury (mmHg). It represents the force that the heart generates each time it contracts. Healthy pulse pressure is around 40 mmHg. A pulse pressure that is consistently 60 mmHg or greater is likely to be associated with disease, and a pulse pressure of 50 mmHg or more increases the risk of cardiovascular disease. Pulse pressure is considered low if it is less than 25% of the systolic. (For example, if the systolic pressure is 120 mmHg, then the pulse pressure would be considered low if it were less than 30 mmHg, since 30 is 25% of 120.) A very low pulse pressure can be a symptom of disorders such as congestive heart failure.
The systemic pulse pressure is approximately proportional to stroke volume, or the amount of blood ejected from the Left Ventricle during systole (pump action) and inversely proportional to the compliance (similar to elasticity) of the aorta.
The most common cause of a low (narrow) pulse pressure is a drop in left ventricular stroke volume.
In trauma, a low or narrow pulse pressure suggests significant blood loss.
A narrow pulse pressure is also caused by aortic stenosis. This is due to the decreased stroke volume in aortic stenosis. Other conditions that can cause a narrow pulse pressure include blood loss (due to decreased blood volume), and cardiac tamponade (due to decreased filling time). In the majority of these conditions, systolic pressure decreases, while diastolic pressure remains normal, leading to a narrow pulse pressure.
In the Postural Orthostatic Tachycardia Syndrome it is postulated that declining venous return reduces stroke volume and frequently results in low pulse pressure. In extreme cases, patients experience a drop in pulse pressure to 0 mm Hg upon standing, rendering them practically pulseless while upright. This condition leads to significant morbidity, as many affected individuals struggle to remain standing. Homan TD, Bordes SJ, Cichowski E (2024), " Physiology, Pulse Pressure", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 29494015, archived from the original on 2024-04-21, retrieved 2024-04-22
The aorta has the highest compliance in the arterial system due in part to a relatively greater proportion of Elastic fiber versus smooth muscle and collagen. This serves to dampen the pulsatile ejection fraction of the left ventricle, thereby reducing the initial systolic pulse pressure, but slightly raising the subsequent diastolic phase. If the aorta becomes rigid, stiff and inextensible because of disorders, such as arteriosclerosis, atherosclerosis or elastin defects (in connective tissue diseases), the pulse pressure would be higher due to less compliance of the aorta.See also: Central aortic blood pressure
In hypertensive patients, a high pulse pressure can often be an indicator of conduit artery stiffness (stiffness of the major arteries). When the arterial walls are stiffer (less compliant), the heart has to beat harder to overcome the resistance from the stiff arteries, resulting in an increased pulse pressure.
Other conditions that can lead to a high pulse pressure include aortic regurgitation, aortic sclerosis, severe iron-deficiency anemia (due to decreased blood viscosity), arteriosclerosis (due to loss of arterial compliance), and hyperthyroidism (due to increased systolic pressure), or arteriovenous malformation, among others. In aortic regurgitation, the aortic valve insufficiency results in the backward flow of blood (regurgitation) that is ejected during systole, and its return to the left ventricle during diastole. This increases the systolic blood pressure, and decreases the diastolic blood pressure, leading to a widened pulse pressure.
A high pulse pressure combined with bradycardia and an irregular breathing pattern is associated with increased intracranial pressure, a condition called Cushing's triad seen in people after head trauma with increased intracranial pressure.
Common causes of widening pulse pressure include:
A meta-analysis in 2000 showed that a 10 mmHg increase in pulse pressure was associated with a 20% increased risk of cardiovascular mortality, and a 13% increase in risk for all coronary end points. The study authors also noted that, while risks of cardiovascular end points do increase with higher systolic pressures, at any given systolic blood pressure the risk of major cardiovascular end points increases, rather than decreases, with lower diastolic levels. This suggests that interventions that lower diastolic pressure without also lowering systolic pressure (and thus lowering pulse pressure) could actually be counterproductive.
People who simultaneously have a resting diastolic pressure of less than 60 mmHg and a pulse pressure of greater than 60 mmHg have double the risk of subclinical myocardial ischaemia and a risk of stroke that is 5.85 times greater than normal. For such patients, it may be dangerous to target a peripheral systolic pressure below 120 mmHg due to the fact that this could cause the diastolic blood pressure in the cerebral cortex in the brain to become so low that perfusion (blood flow) is insufficient, leading to white matter lesions. Nearly all coronary perfusion and more than half of cerebral perfusion occurs during diastole, thus a diastolic pressure that is too low can cause harm to both the heart and the brain.
Increased pulse pressure is also a risk factor for the development of atrial fibrillation.
It has been hypothesized that vasopeptidase inhibitors and nitric oxide donors may be useful at lowering pulse pressure in patients with elevated pulse pressure by increasing the distensibility of the large arteries. There is evidence that glyceryl trinitrate, a nitric oxide donor, may be effective at lowering both pulse pressure and overall blood pressure in patients with acute and sub-acute stroke.
A 2001 randomized, placebo-controlled trial of 1,292 males, compared the effects of hydrochlorothiazide (a thiazide diuretic), atenolol (a beta-blocker), captopril (an ACE inhibitor), clonidine (a central α-agonist), diltiazem (a calcium channel blocker), and prazosin (an α-blocker) on pulse pressure and found that, after one year of treatment, hydrochlorothiazide was the most effective at lowering pulse pressure, with an average decrease of 8.6 mmHg. Captopril and atenolol were equal as least effective, with an average decrease of 4.1 mmHg. Clonidine (decrease of 6.3 mmHg), diltiazem (decrease of 5.5 mmHg), and prazosin (decrease of 5.0 mmHg) were intermediate.
From exercise
Clinical significance
Cardiovascular disease and pulse pressure
Effects of medications on pulse pressure
Pulse pressure and sepsis
See also
|
|